Researchers reviewed the evidence regarding the utility of serum GFAP as a biomarker in neurological diseases and they believed that clinical use of GFAP measurements had the potential to contribute to accelerated diagnosis and improved prognostication38. Here, GFAP is linked to nervous system disorder.